Doxorubicin versus methotrexate both combined with cyclophosphamide, fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer - a randomized study with more than 10 years of follow-up from the Danish Breast Cancer Cooperative Group

M. Anderson; E.L. Madsen; M. Overgaard; C. Rose; P. Dombernowsky; H.T. Mouridsen

Doxorubicin versus methotrexate both combined with cyclophosphamide, fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer - a randomized study with more than 10 years of follow-up from the Danish Breast Cancer Cooperative Group

M. Anderson
, E.L. Madsen
, M. Overgaard
, C. Rose
, P. Dombernowsky
, H.T. Mouridsen

Klinisk Institut

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning

Originalsprog	Engelsk
Tidsskrift	European Journal of Cancer
Vol/bind	35(1)
Sider (fra-til)	39-46
ISSN	0959-8049
Status	Udgivet - 1999

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Anderson, M., Madsen, E. L., Overgaard, M., Rose, C., Dombernowsky, P., & Mouridsen, H. T. (1999). Doxorubicin versus methotrexate both combined with cyclophosphamide, fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer - a randomized study with more than 10 years of follow-up from the Danish Breast Cancer Cooperative Group. European Journal of Cancer, 35(1), 39-46.

Anderson, M. ; Madsen, E.L. ; Overgaard, M. et al. / Doxorubicin versus methotrexate both combined with cyclophosphamide, fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer - a randomized study with more than 10 years of follow-up from the Danish Breast Cancer Cooperative Group. I: European Journal of Cancer. 1999 ; Bind 35(1). s. 39-46.

@article{34a455606fcf11db81a9000ea68e967b,

title = "Doxorubicin versus methotrexate both combined with cyclophosphamide, fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer - a randomized study with more than 10 years of follow-up from the Danish Breast Cancer Cooperative Group",

author = "M. Anderson and E.L. Madsen and M. Overgaard and C. Rose and P. Dombernowsky and H.T. Mouridsen",

year = "1999",

language = "English",

volume = "35(1)",

pages = "39--46",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier",

}

Anderson, M, Madsen, EL, Overgaard, M, Rose, C, Dombernowsky, P & Mouridsen, HT 1999, 'Doxorubicin versus methotrexate both combined with cyclophosphamide, fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer - a randomized study with more than 10 years of follow-up from the Danish Breast Cancer Cooperative Group', European Journal of Cancer, bind 35(1), s. 39-46.

Doxorubicin versus methotrexate both combined with cyclophosphamide, fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer - a randomized study with more than 10 years of follow-up from the Danish Breast Cancer Cooperative Group. / Anderson, M.; Madsen, E.L.; Overgaard, M. et al.
I: European Journal of Cancer, Bind 35(1), 1999, s. 39-46.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning

TY - JOUR

T1 - Doxorubicin versus methotrexate both combined with cyclophosphamide, fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer - a randomized study with more than 10 years of follow-up from the Danish Breast Cancer Cooperative Group

AU - Anderson, M.

AU - Madsen, E.L.

AU - Overgaard, M.

AU - Rose, C.

AU - Dombernowsky, P.

AU - Mouridsen, H.T.

PY - 1999

Y1 - 1999

M3 - Journal article

SN - 0959-8049

VL - 35(1)

SP - 39

EP - 46

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Anderson M, Madsen EL, Overgaard M, Rose C, Dombernowsky P, Mouridsen HT. Doxorubicin versus methotrexate both combined with cyclophosphamide, fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer - a randomized study with more than 10 years of follow-up from the Danish Breast Cancer Cooperative Group. European Journal of Cancer. 1999;35(1):39-46.